Skip to main content

Depression and HIV Webinar

Thank you

This live web event has ended. Thank you for attending.


1.0 CEUs
Depression and HIV

Webinar Description
This webinar will provide an overview of depression and HIV. Depression is one of the most common mental health disorders faced by people with HIV. Depression can be exacerbated by the stigma associated with HIV, isolation in older persons with HIV, and shame among young people. Cisgender women with HIV experience depression at higher rates than their cisgender male counterparts. As well, studies suggest that HIV can directly and indirectly impact hormone signaling, a phenomenon which may contribute to higher rates of depression among people with HIV.

Depressed mood and cognitive impairment are also associated with increased risk-taking behavior, and depression may also mediate the effectiveness of interventions, such as consistent and correct condom use, to decrease secondary transmission.

Designed for the HIV health care professional, this webinar will look at the clinical manifestation of depression and HIV, diagnostic criteria, etiology and physiology of depression's impact on health, and evidence-based interventions - including the prescribing and monitoring of psychotropic medications.

Program Agenda
1:00 p.m. – 1:05 p.m.: Welcome, Introductions
1:05 p.m. – 1:45 p.m.: Keynote Address
1:45 p.m. – 2:00 p.m.: Q&A/Adjourn
Learning Objectives
  • Examine the prevalence, differential diagnosis, socio-cultural contexts, prognosis, and associated traits of mental health and substance use disorders among people with HIV.
  • Share the diagnostic criteria of the significant mental health and substance use disorders among people with HIV.
  • Evaluate the etiology and physiological effects of mental health and substance use disorders among people with HIV.
  • Outline how clinicians can utilize validated tools and resources to assess the mental status of people with HIV to determine the need for referral to a mental health provider for testing or treatment.
  • Summarize evidence-based treatment interventions, prescribing, and monitoring best practices for mental health and substance use disorders for people with HIV.


  • Karl Goodkin, MD, PhD, DLFAPA, FACPsych, FRSM

    Department of Psychiatry Chair
    University of Texas Rio Grand Valley School of Medicine
    Rio Grand Valley, TX

October 26, 2023
Thu 1:00 PM EDT

Duration 1H 0M

This live web event has ended.

Education Department